TCG Crossover Management, LLC - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 47 filers reported holding ENTRADA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
TCG Crossover Management, LLC ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,242,289
+4.4%
584,9550.0%1.36%
-6.3%
Q2 2023$8,856,219
+4.4%
584,9550.0%1.45%
-12.2%
Q1 2023$8,481,848
+7.2%
584,9550.0%1.65%
+18.4%
Q4 2022$7,908,592
-21.9%
584,955
-8.9%
1.40%
-54.0%
Q3 2022$10,121,000
+25.2%
642,189
-3.2%
3.04%
-11.6%
Q2 2022$8,084,000
+31.8%
663,6940.0%3.43%
+39.5%
Q1 2022$6,133,000
-46.0%
663,6940.0%2.46%
-53.7%
Q4 2021$11,362,000663,6945.32%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 509,023$7,706,60860.04%
MPM ASSET MANAGEMENT LLC 4,425,784$67,006,37032.86%
5AM Venture Management, LLC 4,408,379$66,742,85816.63%
StepStone Group LP 761,277$11,525,7342.13%
TCG Crossover Management, LLC 584,955$8,856,2191.45%
Redmile Group, LLC 1,311,572$19,857,2000.76%
Nan Fung Group Holdings Ltd 49,082$743,1010.48%
Baker Brothers Advisors 4,865,819$73,668,5000.43%
Corton Capital Inc. 18,067$273,5340.13%
MOORE CAPITAL MANAGEMENT, LP 105,000$1,589,7000.03%
View complete list of ENTRADA THERAPEUTICS INC shareholders